KalVista Pharmaceuticals Acquired by Chiesi Farmaceutici | Healthcare M&A Deal

Chiesi Farmaceutici has agreed to acquire KalVista Pharmaceuticals, a pharmacy business in the United States, for $27.00 per share in cash. KalVista Pharmaceuticals develops and commercializes specialty medicines, supporting Chiesi Farmaceutici acquisitions in healthcare M&A and pharmacy acquisition strategy. The going private acquisition is structured through Skyline Merger Sub, a wholly owned subsidiary of Chiesi Farmaceutici, to acquire all outstanding shares of KalVista Pharmaceuticals, Inc. Chiesi Farmaceutici acquisitions are positioned as a strategic acquisition and going private acquisition, with the tender offer filing submitted to the U.S. Securities and Exchange Commission as an amendment to the Schedule TO.